ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P951. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,301,972 | +34.0% | 67,300 | +27.7% | 0.00% | 0.0% |
Q2 2023 | $4,703,475 | +7.8% | 52,700 | +29.5% | 0.00% | 0.0% |
Q1 2023 | $4,363,854 | +16.8% | 40,700 | +33.0% | 0.00% | 0.0% |
Q4 2022 | $3,737,178 | +109.2% | 30,600 | +76.9% | 0.00% | +100.0% |
Q3 2022 | $1,786,000 | -47.8% | 17,300 | -53.0% | 0.00% | 0.0% |
Q2 2022 | $3,421,000 | – | 36,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANE STREET GROUP, LLC | 40,700 | $4,363,854 | 0.00% |
SIMPLEX TRADING, LLC | 12,500 | $1,340 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |